JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and HekaBio K.K.
Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventela and Professor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback